In this database, useful information about carbohydrate antigens, ie, glycoepitopes, and antibodies is organized as a compact encyclopedia.
Source | Last Updated |
---|---|
GlycoEpitope | November 18, 2015 |
Epitope ID | Epitope Name | Epitope Sequence |
---|---|---|
EP0059 | GD1b | Gal(b1-3)GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
EP0061 | GD2 | GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
EP0062 | N-Acetyl GD3 | Neu5Ac(a2-8)Neu5Ac(a2-3)Gal(b1-4)Glc(b1-1)Cer |
EP0063 | N-Glycolyl GD3 | Neu5Gc(a2-8)Neu5Gc(a2-3)Gal(b1-4)Glc(b1-1)Cer |
EP0064 | 9-O-Acetyl GD3 | Neu5Ac9Ac(a2-8)Neu5Ac(a2-3)Gal(b1-4)Glc(b1-1)Cer |
EP0065 | 9-O-Acetyl Sialic Acid | Neu5Ac9Ac(a2-)-R |
EP0066 | GT1a | Neu5Ac(a2-8)Neu5Ac(a2-3)Gal(b1-3)GalNAc(b1-4)[Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
EP0067 | GT1b | Neu5Ac(a2-3)Gal(b1-3)GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
EP0068 | Bata Galactose | Gal(b1-)-R-Cer |
EP0069 | GQ1b | Neu5Ac(a2-8)Neu5Ac(a2-3)Gal(b1-3)GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
EP0070 | GT3 | Neu5Ac(a2-8)Neu5Ac(a2-8)Neu5Ac(a2-3)Gal(b1-4)Glc(b1-1)Cer |
EP0071 | Gb3 | Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer |
EP0072 | Gal-CTH | Gal(a1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer |
EP0073 | Globoside | GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer |
EP0074 | Galactosylceramide | Gal(b1-1)Cer |
EP0075 | Paragloboside | Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer |
EP0076 | 2-3 Sialylparagloboside | Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer |
EP0077 | 2-6 Sialylparagloboside | Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer |
EP0078 | Lactosylceramide | Gal(b1-4)Glc(b1-1)Cer |
EP0079 | SM3 | HSO3(-3)Gal(b1-4)Glc(b1-1)Cer |
EP0080 | SD1a | HSO3(-3)Gal(b1-3)GalNAc(b1-4)[HSO3(-3)]Gal(b1-4)Glc(b1-1)Cer |
EP0081 | Chondroitin | -[GlcA(b1-3)GalNAc(b1-4)]n- |
EP0082 | Chondroitin-4-Sulfate | -{GlcA(b1-3)[HSO3(-4)]GalNAc(b1-4)}n- |
EP0083 | Chondroitin-6-Sulfate | -{GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
EP0084 | Chindroitin Sulfate D Unit | -{[HSO3(-2)]GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
EP0085 | Keratan Sulfate | -{HSO3(-6)GlcNAc(b1-3)±[HSO3(-6)]Gal(b1-4)}n- |
EP0086 | Heparan Sulfate | -[{[±(HSO3(-2))GlcA(b1-4)]or[±(HSO3(-2))IdoA(a1-4)]}(±(HSO3(-3))±[(HSO3 or CH3CO)(-2)]±(HSO3(-6))GlcN]n- |
EP0087 | Delta-Heparan Sulfate | unsaturated uronic acid |
EP0088 | Acharan Sulfate | -{[HSO3(-2)]IdoA(a1-4)GlcNAc(a1-4)}n- |
EP0090 | Dimeric Lewis a | Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
EP0091 | Lewis a- Lewis x Hybrid Antigen | Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
EP0092 | Trifucosyl-Lewis b Antigen | Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
EP0093 | Dimeric Lewis x | Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
EP0094 | Trifucosyl-Lewis y Antigen | Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
EP0095 | Disialyl I | Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-6)[Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)GlcNAc(b1-)-R |
EP0096 | Disialyl Lewis c | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GlcNAc(b1-)-R |
EP0097 | GalNAc Disialyl Lc4 (Hexasaccharide) | GalNAc(b1-4)[NeuAc(a2-3)]Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-3)Gal-R |
EP0098 | Disialyl Gb5 | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer |
EP0099 | Monosialyl Gb5 | Neu5Ac(a2-3)Gal(b1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer |
EP0101 | Poly-N-Acetylneuraminic Acid | (Neu5Ac) n |
EP0102 | Poly-N-Glycolylneuraminic Acid | (Neu5Gc)n |
EP0103 | Poly-KDN | (KDN)n |
EP0104 | KDN-Gal | KDN(a2-3)Gal(b1-)-R |
EP0110 | GD1 alpha(Pentasaccharide) | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)Gal-R |
EP0111 | GT1a alpha | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
EP0112 | GQ1b alpha | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
EP0113 | Galabiosylceramide | Gal(a1-4)Gal(b1-1)Cer |
EP0114 | Lactotetraosylceramide | Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer |
EP0115 | 2-9,2-6 Disialyllactosylceramide | Neu5Ac(a2-9)Neu5Ac(a2-6)Gal(b1-4)Glc(b1-1)Cer |
EP0120 | SM4s | HSO3(-3)Gal(b1-1)Cer |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024